SCHEMBL2162573

SCHEMBL2162573

CC1OCc2sc(N)c(C(=O)C3CC3)c21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 15/20 0.38
MAPT P10636 14/20 0.38
HPGD P15428 9/20 0.38
KDM4E B2RXH2 9/20 0.38
ALOX15 P16050 4/20 0.38
HSD17B10 Q99714 4/20 0.38
CNR1 P21554 2/20 0.37
CNR2 P34972 2/20 0.37
GAA P10253 5/20 0.33
TSHR P16473 2/20 0.33
ALOX12 P18054 1/20 0.33
LMNA P02545 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
ANO1 Q5XXA6 1/20 0.33
MEN1 O00255 4/20 0.32
KMT2A Q03164 4/20 0.32
ADORA1 P30542 1/20 0.32
RAD52 P43351 1/20 0.32
GLA P06280 1/20 0.32
NPC1 O15118 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2162345 0.94 CNR1 (0.38) ALDH1A1MAPTHPGDKDM4EALOX15
SCHEMBL2162393 0.94 CNR1 (0.38) ALDH1A1MAPTHPGDKDM4EALOX15
SCHEMBL2162281 0.76 ALDH1A1 (0.54) ALDH1A1MAPTHPGDKDM4EALOX15
SCHEMBL2162192 0.76 ALDH1A1 (0.50) ALDH1A1MAPTHPGDHSD17B10GAA
SCHEMBL2162435 0.72 ALDH1A1 (0.37) ALDH1A1MAPTHPGDKDM4EALOX15
SCHEMBL5453373 0.71 FLT3 (0.54) ALDH1A1MAPTHPGDKDM4EHSD17B10
SCHEMBL20339216 0.71 ALOX15 (0.42) MAPTALOX15CNR1CNR2ALOX12
SCHEMBL2162128 0.70 CNR2 (0.44) ALDH1A1MAPTHPGDKDM4EHSD17B10
SCHEMBL2162111 0.69 CNR2 (0.48) CNR1CNR2ADORA1
SCHEMBL2162410 0.67 CNR1 (0.46) ALDH1A1KDM4ECNR1CNR2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7985768-B2 2-carbonylamino-4,6-dihydrothieno[2,3-c]furans such as ethyl 2-{[2-fluoro-6-(trifluoromethyl)benzoyl]amino}-4-methyl-4,6-dihydrothieno[2,3-c]furan-3-carboxylate; CB2 receptors ligands for immune and inflammatory conditions; pain; neuroprotectants ABBOTT LABORATORIES (US) 2011-07-26 US disclosed
US-20080058308-A1 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS ABBOTT LABORATORIES (US) 2008-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058308-A1 NOVEL COMPOUNDS AS CANNABINOID RECEPTOR LIGANDS CNR1, CNR2, OPRL1 ALDH1A1 1497/4885MAPT 1751/4885HPGD 2820/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.